News

Biomednewsbreaks Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 20252026 Catalysts Across Rare Disease Pipeline
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a sharehold ...
APAnews12h
Malawi second African country to launch disease surveillance plan
Malawi at forefront of disease detection and pandemic preparedness in Africa after launching multi-pathogen genomic ...
Gold Coast Sun14h
Long Shortz with Island Pharma: Targeting Ebola, Zika & Marburg with Gallidesivir
The broad-spectrum drug targets deadly viruses like Ebola, Marburg, and Zika, and Island plans to pursue FDA approval under ...
AllAfrica20h
Malawi Launches Second Edition of Pathogen Genomic Surveillance Strategy and Implementation Plan
The Malawi Ministry of Health, launched its updated plan for the implementation of its Genomic Surveillance Strategy that was produced with technical support from the Africa Centres for Disease ...
Small Caps20h
Island Pharmaceuticals Expedites Purchase of Galidesivir RNA Anti-Viral Program
Anti-viral drug development company Island Pharmaceuticals (ASX: ILA) has expedited its US$550,000 acquisition of the ...
Stockhead on MSN22h
Health Check: POTUS puts drug tariffs back on agenda… another case of TACO?
POTUS threatens a foreign drug tariff, but gives Big Pharma more time to shift production onshore ASX drug makers say they ...
Stockhead on MSN23h
Island fast tracks portfolio expansion with acquisition of Galidesivir for ‘high-priority threat’ viruses
Island Pharmaceuticals has signed an asset purchase agreement to buy the Galidesivir antiviral program targeting ...